284 related articles for article (PubMed ID: 22294550)
1. Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Shahidi N; Fu YT; Qian H; Bressler B
Inflamm Bowel Dis; 2012 Nov; 18(11):2034-42. PubMed ID: 22294550
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
[TBL] [Abstract][Full Text] [Related]
3. T-cell profiling and the immunodiagnosis of latent tuberculosis infection in patients with inflammatory bowel disease.
Arias-Guillén M; Riestra S; de Francisco R; Palacios JJ; Belda J; Escalante P; Pérez-Martínez I; Molinos LM; Garcia-Clemente M; Pando-Sandoval A; Rodrigo L; Prieto A; Martínez-Camblor P; Losada A; Casan P
Inflamm Bowel Dis; 2014 Feb; 20(2):329-38. PubMed ID: 24378597
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
5. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
[TBL] [Abstract][Full Text] [Related]
6. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
[TBL] [Abstract][Full Text] [Related]
7. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
[TBL] [Abstract][Full Text] [Related]
8. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
9. Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: a systemic review and meta-analysis.
Ruan Q; Zhang S; Ai J; Shao L; Zhang W
Clin Rheumatol; 2016 Feb; 35(2):417-25. PubMed ID: 25376466
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of tuberculin skin test and three interferon-gamma release assays for the differential diagnosis of pulmonary tuberculosis.
Kobashi Y; Abe M; Mouri K; Obase Y; Miyashita N; Oka M
Intern Med; 2012; 51(10):1199-205. PubMed ID: 22687790
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.
Vassilopoulos D; Tsikrika S; Hatzara C; Podia V; Kandili A; Stamoulis N; Hadziyannis E
Clin Vaccine Immunol; 2011 Dec; 18(12):2102-8. PubMed ID: 21994356
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
Ayubi E; Doosti-Irani A; Sanjari Moghaddam A; Sani M; Nazarzadeh M; Mostafavi E
PLoS One; 2016; 11(9):e0161983. PubMed ID: 27622293
[TBL] [Abstract][Full Text] [Related]
14. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
15. Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection.
De Keyser E; De Keyser F; De Baets F
Acta Clin Belg; 2014 Oct; 69(5):358-66. PubMed ID: 25018132
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the 2-step tuberculin skin test and the quantiFERON-TB Gold In-Tube Test for the screening of tuberculosis infection before liver transplantation.
Casas S; Muñoz L; Moure R; Castellote J; Guerra MR; Gonzalez L; Andreu A; Rafecas AG; Alcaide F; Santin M
Liver Transpl; 2011 Oct; 17(10):1205-11. PubMed ID: 22279622
[TBL] [Abstract][Full Text] [Related]
17. Disease activity is an important factor for indeterminate interferon-γ release assay results in children with inflammatory bowel disease.
Hradsky O; Ohem J; Zarubova K; Mitrova K; Durilova M; Kotalova R; Nevoral J; Zemanova I; Dryak P; Bronsky J
J Pediatr Gastroenterol Nutr; 2014 Mar; 58(3):320-4. PubMed ID: 24126833
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis.
Chiappini E; Accetta G; Bonsignori F; Boddi V; Galli L; Biggeri A; De Martino M
Int J Immunopathol Pharmacol; 2012; 25(3):557-64. PubMed ID: 23058005
[TBL] [Abstract][Full Text] [Related]
19. Systemic review: agreement between the latent tuberculosis screening tests among patients with rheumatic diseases.
Pyo J; Cho SK; Kim D; Sung YK
Korean J Intern Med; 2018 Nov; 33(6):1241-1251. PubMed ID: 29277097
[TBL] [Abstract][Full Text] [Related]
20. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
